This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chen, J. J. Articles by Swope, D. M. Search for Related Content Social Bookmarking                         What's this?

Essential Tremor

Schools of Medicine and Pharmacy, Loma Linda University, Loma Linda, California, jjchen{at}llu.edu

David M. Swope, MD

Department of Neurology and School of Medicine, Loma Linda University, Loma Linda, California

Essential tremor is a common movement disorder that interferes with the performance of motor tasks and social activities. As a consequence, patients experience a reduction in quality of life. The pathophysiology remains not well understood. Differentiation of essential tremor from other tremor syndromes is important in order for clinicians to better provide patient education and therapy. When pharmacotherapy is indicated, the standard agents remain propranolol and primidone. However, additional agents such as benzodiazepines, gabapentin, topiramate, and zonisamide may provide additional symptomatic benefits. Surgical interventions, such as thalamic deep brain stimulation, and focal injections of botulinum toxin offer patients an alternative treatment modality when oral pharmacotherapy is inadequate. A treatment outline is provided to guide clinicians in the management of patients with essential tremor.

Key Words: Essential tremor • movement disorder • pharmacotherapy.

Journal of Pharmacy Practice, Vol. 20, No. 6, 458-468 (2007)
DOI: 10.1177/0897190007311453


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?